RxDoctor Payments Data

Samuel Penziner

Hospitalist · Los Angeles, CANPI 1073900809

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,242 of the $1,473 with a category attached, or 84.3%. Every reported general payment came from a single manufacturer, Merck. Among hospitalist clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,473in general payments, 2019–2025

Across 8 payments — averaging $184.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1K
$2,452,115in research payments, 2019–2025

Across 1,682 payments — averaging $1457.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$1.4M
  • AstraZeneca$331K
  • Chiesi USA, Inc.$292K
  • Sanofi Pasteur Inc.$172K
  • Eli Lilly$155K
  • Pfizer$50K
  • plus $50K from 5 others

What the payments were for

  • Travel & lodging$1,24284%
  • Food & beverage$23216%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck8$1,473

How this compares

$1,473 in reported general payments places this provider in the 90th percentile of 2,469 hospitalist providers in California.

See all hospitalist providers in California →

Other hospitalist in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →